KYNMOBI
210875 | Orange Book
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Patent | Expiration |
---|---|
10,888,499 | 2 years, 11 months ago |
11,077,068 | 2 years, 11 months ago |
9,855,221 | 2 years, 11 months ago |
9,931,305 | 2 years, 11 months ago |
8,663,687 | 1 year, 11 months ago |
8,765,167 | 11 months, 1 week ago |
8,603,514 | 9 months, 4 weeks ago |
10,821,074 | 4 years, 6 months from now |
10,420,763 | 5 years, 4 months from now |
9,044,475 | 5 years, 4 months from now |
9,283,219 | 5 years, 4 months from now |
9,326,981 | 5 years, 4 months from now |
9,669,019 | 5 years, 4 months from now |
9,669,021 | 5 years, 4 months from now |
8,414,922 | 6 years, 10 months from now |
8,846,074 | 6 years, 10 months from now |
10,449,146 | 11 years, 2 months from now |
10,959,943 | 11 years, 2 months from now |
Date | Patent / Filing No. | Patent and Drug Application Information |
---|---|---|
4/19/2036 | 10959943 | Expiration of Patent No 10,959,943: (U-2825). |
4/19/2036 | 10449146 | Expiration of Patent No 10,449,146: (U-2825). |
12/16/2031 | 8846074 | Expiration of Patent No 8,846,074: (U-2825). (drug product) |
12/16/2031 | 8414922 | Expiration of Patent No 8,414,922: (U-2825). (drug product) |
6/11/2030 | 9669021 | Expiration of Patent No 9,669,021: (U-2825). |
6/11/2030 | 9669019 | Expiration of Patent No 9,669,019: (U-2825). (drug product) |
6/11/2030 | 9326981 | Expiration of Patent No 9,326,981: (U-2825). |
6/11/2030 | 9283219 | Expiration of Patent No 9,283,219: (U-2825). (drug product) |
6/11/2030 | 9044475 | Expiration of Patent No 9,044,475: (drug product) |
6/11/2030 | 10420763 | Expiration of Patent No 10,420,763: (U-2825). (drug product) |
8/7/2029 | 10821074 | Expiration of Patent No 10,821,074: (drug product) |
4/3/2024 | 8603514 | Expiration of Patent No 8,603,514: (drug product) |
2/20/2024 | 8765167 | Expiration of Patent No 8,765,167: (drug product) |
2/2/2023 | 8663687 | Expiration of Patent No 8,663,687: (drug product) |
5/5/2022 | SUPPL-7 | Labeling-Package Insert, Labeling-Patient Package Insert: |
2/14/2022 | 9931305 | Expiration of Patent No 9,931,305: (drug product) |
2/14/2022 | 9855221 | Expiration of Patent No 9,855,221: (drug product) |
2/14/2022 | 11077068 | Expiration of Patent No 11,077,068: (drug product) |
2/14/2022 | 10888499 | Expiration of Patent No 10,888,499: (drug product) |
5/21/2020 | Approval for KYNMOBI, 30MG
| |
5/21/2020 | Approval for KYNMOBI, 25MG
| |
5/21/2020 | Approval for KYNMOBI, 20MG
| |
5/21/2020 | Approval for KYNMOBI, 15MG
| |
5/21/2020 | Approval for KYNMOBI, 10MG
| |
5/21/2020 | ORIG-1 | Approval:
|